EGFR and lung carcinoma: The present paper reviews the role of EMT in the interplay between tumor cells and the immune system, highlighting the molecular mechanisms that promote tumor development and aggressiveness and focusing in depth on putative strategies to overcome EMT-mediated resistance to epidermal growth factor receptor (EGFR) and tyrosine kinase inhibitors (TKIs) in lung cancer.